Detalles de la búsqueda
1.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943171
2.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
3.
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 21(10)2020 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429381
4.
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.
Breast J
; 25(6): 1225-1229, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31310384
5.
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Oncology
; 93(1): 62-66, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407622
6.
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 16(3)2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339347
7.
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.
Front Oncol
; 13: 1154581, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37035150
8.
High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report.
Front Oncol
; 13: 1307573, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38370346
9.
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Crit Rev Oncol Hematol
; 190: 104089, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562696
10.
Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis.
Cancer Manag Res
; 14: 3507-3523, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575665
11.
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives.
Front Oncol
; 11: 769280, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34900718
12.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Ther Adv Med Oncol
; 13: 17588359211059873, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173816
13.
Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane.
Medicine (Baltimore)
; 99(31): e21211, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756099
14.
Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial.
Cancers (Basel)
; 12(4)2020 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32244657
15.
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
J Exp Clin Cancer Res
; 39(1): 279, 2020 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33302999
16.
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer.
J Clin Med
; 8(2)2019 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30781624
17.
Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report.
Medicine (Baltimore)
; 98(37): e17135, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31517852
18.
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios.
J Cancer
; 10(24): 5903-5914, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762800
19.
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
J Thorac Oncol
; 14(11): 1924-1934, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31323387
20.
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Cancer Biol Ther
; 20(2): 192-200, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30403909